Synthetic Drug Abuse Prevention Act of 2012

S. 3187 — 112th Congress
(2011–2012)

Summary

A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes. (by CRS)

A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes.

On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.

6/20/2012

Motion to reconsider laid on the table Agreed to without objection.

6/20/2012

Message on House action received in Senate and at desk: House amendment to Senate bill.

6/21/2012

Measure laid before Senate by unanimous consent.

6/21/2012

Motion to concur in the House amendment made in Senate.

6/21/2012

Cloture motion on the motion to concur in the House amendment presented in Senate.

6/21/2012

Motion to concur in the House amendment with an amendment (SA 2461) made in Senate.

6/21/2012

Motion by Senator Reid to refer to Senate Committee on Health, Education, Labor, and Pensions with instructions to report back forthwith with the following amendment (SA 2463) made in Senate.

6/21/2012

Amendment SA 2461 proposed by Senator Reid.

6/21/2012

Amendment SA 2462 proposed by Senator Reid to Amendment SA 2461.

6/21/2012

Amendment SA 2463 (the instructions to the motion) proposed by Senator Reid.

6/21/2012

Amendment SA 2464 proposed by Senator Reid to Amendment SA 2463.

6/21/2012

Amendment SA 2465 proposed by Senator Reid to Amendment SA 2464.

6/25/2012

Motion by Senator Reid to refer to Senate Committee on Health, Education, Labor, and Pensions with instructions to report back forthwith with the following amendment (SA 2463) fell when cloture on the motion to concur in the House amendment to the bill (S. 3187) was invoked in Senate.

6/25/2012

SA 2463 (instructions to the motion to refer) fell when cloture invoked on the motion to concur in the House amendment to the bill (S.3187).

To provide substantial savings in health care costs to the Federal government and consumers by fostering competition among generic pharmaceutical manufacturers and ensuring that anti-competitive "pay-for-delay" settlements between brand-name and generic pharmaceutical manufacturers do not block generic drugs from entering the market.

To ensure that adequate information is disseminated to health care providers and payors about the potential benefits and risks of medical products on all patient populations, particularly underrepresented subpopulations, including racial subgroups.

To provide deadlines for the issuance of certain regulations and to require a GAO report on the implementation of the clinical trial registration and reporting requirements under the Public Health Service Act.

To provide that a portion of the performance awards of each employee of the Center for Drug Evaluation and Research, the Center for Devices and Radiological Health, and the Center for Biologics Evaluation and Research be connected to an evaluation of the employee's contribution to goals under the user fee agreements.

To amend the Federal Food, Drug, and Cosmetic Act concerning claims about the effects of foods and dietary supplements on health-related conditions and disease, to prohibit employees of the Food and Drug Administration from carrying firearms and making arrests without warrants, and to adjust the mens rea of certain prohibited acts under the Federal Food, Drug, and Cosmetic Act to knowing and willful.

Organizations that took a position on
Synthetic Drug Abuse Prevention Act of 2012: Amendment SA 2145 as modified agreed to in Senate by Unanimous Consent.

0 organizations supported this amendment

0 organizations opposed this amendment

Need proof?

Includes reported contributions to congressional campaigns of Senators in office on day of vote, from interest groups invested in the vote according to MapLight, January 1, 2007 – December 31, 2012.Contributions data source: OpenSecrets.org